Global and United States Cerebrovascular Disease Market Report & Forecast 2022-2028

Cerebrovascular diseases are a group of condition characterized by a certain dysfunction of blood vessels supplying the brain and also affect the flow of blood in an individual’s brain. For proper functioning of the brain, it needs certain nutrients and oxygen from the arteries. However, if there is any kind of restriction in the blood flow, the brain cells begin to die. The prime causes of cerebrovascular disease are cerebral thrombosis, cerebral embolism, and cerebral hemorrhage. Due to cerebrovascular disease, part of the brain is affected due to bleeding and thereby leads to different types of cerebrovascular diseases such as stroke, transient ischaemic attack (TIA), vascular dementia, and subarachnoid hemorrhage.
Market Analysis and Insights: Global and United States Cerebrovascular Disease Market
This report focuses on global and United States Cerebrovascular Disease market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Cerebrovascular Disease market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Carotid Endarterectomy accounting for % of the Cerebrovascular Disease global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Academic & Research Institutes was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
According to Centers for Disease Control and Prevention, cerebrovascular disease is the fourth most common cause of death in the U.S. Following North America, European countries are also expected to show steady growth in the market. In the next few years, Asia-Pacific would show remarkable growth in the cerebrovascular disease market as it is developing at a very rapid pace. The factors which would fuel the growth of the market in Asia Pacific are increasing awareness about cerebrovascular disease, certain family history related to the disease and rapidly developing technologically advanced treatments.
Global Cerebrovascular Disease Scope and Market Size
Cerebrovascular Disease market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cerebrovascular Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Cerebrovascular Disease market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
Carotid Endarterectomy
Carotid Angioplasty Or Carotid Artery Stenting
Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)

Segment by Application
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Contract Research Organizations
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Johnson & Johnson
Amgen
GlaxoSmithKline
Sanofi-Aventis
Merck
Sangamo BioSciences
Aldagen